LCM
GILD icon

LCM Capital Management’s Gilead Sciences GILD Stock Holding History

LCM Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.14M Buy
8,991
+163
+2% +$21.5K 0.49% 34
2026
Q1 		$1.23M Buy
8,828
+58
+0.7% +$8.12K 0.62% 27
2025
Q4 		$1.08M Sell
8,770
-910
-9% -$111K 0.52% 33
2025
Q3 		$1.07M Sell
9,680
-27
-0.3% -$3.07K 0.52% 33
2025
Q2 		$1.08M Buy
9,707
+56
+0.6% +$5.96K 0.56% 33
2025
Q1 		$1.08M Buy
9,651
+224
+2% +$23.1K 0.64% 30
2024
Q4 		$871K Buy
9,427
+31
+0.3% +$2.79K 0.49% 39
2024
Q3 		$788K Buy
9,396
+206
+2% +$15.7K 0.45% 40
2024
Q2 		$631K Buy
9,190
+237
+3% +$15.8K 0.39% 41
2024
Q1 		$656K Buy
8,953
+19
+0.2% +$1.46K 0.42% 42
2023
Q4 		$724K Buy
8,934
+23
+0.3% +$1.79K 0.52% 34
2023
Q3 		$668K Buy
8,911
+412
+5% +$31.7K 0.54% 33
2023
Q2 		$655K Buy
8,499
+113
+1% +$9.01K 0.53% 35
2023
Q1 		$696K Buy
8,386
+451
+6% +$37.4K 0.61% 33
2022
Q4 		$681K Buy
7,935
+5
+0.1% +$396 0.66% 30
2022
Q3 		$489K Sell
7,930
-32
-0.4% -$2.02K 0.52% 35
2022
Q2 		$492K Sell
7,962
-2
-0% -$124 0.48% 40
2022
Q1 		$473K Buy
7,964
+330
+4% +$21.1K 0.38% 47
2021
Q4 		$554K Buy
7,634
+317
+4% +$21.8K 0.43% 44
2021
Q3 		$511K Buy
7,317
+18
+0.2% +$1.26K 0.43% 46
2021
Q2 		$503K Sell
7,299
-134
-2% -$8.95K 0.42% 45
2021
Q1 		$480K Sell
7,433
-272
-4% -$17.5K 0.43% 46
2020
Q4 		$449K Buy
+7,705
New +$465K 0.43% 43

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LCM Capital Management's GILD Position: Q2 2026 in Review

LCM Capital Management increased its Gilead Sciences (GILD) stake by 1.8% in Q2 2026, buying an estimated $21.5K and bringing the position to 8,991 shares worth $1.14M. The position accounts for 0.49% of the portfolio, ranked #34.

LCM Capital Management first reported a position in GILD in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.23M in Q1 2026. 2,283 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • LCM Capital Management held 8,991 shares of Gilead Sciences worth $1.14M as of Q2 2026.
  • LCM Capital Management bought 163 Gilead Sciences shares in Q2 2026, an estimated $21.5K.
  • Gilead Sciences made up 0.49% of LCM Capital Management's portfolio in Q2 2026, its #34 holding.
  • LCM Capital Management first reported a position in Gilead Sciences in Q4 2020 and has held it in 23 quarters since.
  • LCM Capital Management's Gilead Sciences position peaked at $1.23M in Q1 2026.
  • 2,283 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on LCM Capital Management's 13F filing for Q2 2026, filed 30 Jul 2026.